PRISMA 声明在评价《循证医学》刊载的干预类系统评价／荟萃分析报告质量中的应用

摘要

目的：评价PRISMA声明对发表于《循证医学》杂志的干预类系统评价/Meta分析报告质量的影响。方法：根据纳入排除标准，纳入2001-2011年发表于《循证医学》的干预性试验系统评价/Meta分析，采用PRISMA量表对纳入系统评价/Meta分析进行评价，用Meta Analyst软件进行统计分析。结果：共纳入70个系统评价/Meta分析，涉及14个疾病谱。 PRISMA的发布和高校作者发表的系统评价/Meta分析，可以提高其报告质量（P＜0．05），基金资助和作者数量对文献报告质量影响不大。结论：发表于《循证医学》杂志的系统评价/Meta分析在文献检索、筛选、偏倚评估和其他分析方法等方面亟待改善，报告质量有待提高。 PRISMA的发布可在整体上改善系统评价/Meta分析的报告质量。%Objective To assess the effect of PRISMA statement on intervention-related systematic reviews and meta-analyses published in Evidence-based medicine .Methods Intervention-related systematic reviews and meta-analyses published in Evidence-based medicine from 2001 to 2011 were assessed according to the PRISMA scale and analyzed by Meta Analysist software.Results Seventy intervention-related systematic reviews and meta-analyses involving 14-disease spectra were included in this study.PRISMA statement and systematic reviews and meta-analysespublished by au-thors in colleges and universities could improve their academic level (P<0.05), fund support and the number of authors showed no significant effect on their academic level.Conclusion Literature retrieval methods,literature screening methods,bias assessment methods, and other analyzing methods used systematic reviews and meta-analyses published in Evidence-based medicine and their academic level can be improved by PRISMA statement.